Biotredin ® is a regulator of tissue metabolism, increases mental Started-tiveness, has a therapeutic effect with alcohol withdrawal state, reduces the craving for alcohol.
Of L-threonine in the presence of testosterone propionate (vitamin B 6 ) breaks down into amino acids glycine and acetaldehyde, which stimulate the processes of inhibition and at the same time redox reactions, the processes of respiration and the synthesis of adenosine triphosphate (ATP) in the cells, whereby the drug is able to:
• reduce emotional stress;
• improve the short-term and long-term memory;
• enhances mental performance;
• improve and normalize the levels of endogenous acetaldehyde and, thus, reduce the effect of alcohol withdrawal symptoms and craving for alcohol.
Action Biotredina manifested in 10-20 minutes after administration under the tongue.
Pharmacokinetics . L-threonine and testosterone propionate completely metabolized to the final products. Cumulation of the body does not occur.
Indications for use.
Assign children, adolescents and adults with a decrease in mental performance and concentration. The drug is prescribed for persons who abuse alcohol, patients with chronic alcoholism at the actualization of a pathological inclination to alcohol, coupled with affective (irritability, depressed mood, internal discomfort), sensory (hunger) and ideational (thoughts about alcohol) disorders, with alcohol withdrawal syndrome, and and to maintain remission.
Alcohol intoxication, concomitant use of drugs which depress the central nervous system (anxiolytic, antipsychotic drugs (neuroleptics), antidepressants, etc.), Increased sensitivity to vitamin B 6 .
Pregnancy and lactation:
individual studies have been conducted. Not recommended for use during pregnancy and lactation. When alcohol abuse and alcoholism, the drug can be used in pregnancy and during breastfeeding.
Dosage and administration:
drug administered in a sublingual tablet or as a powder after grinding tablets; as a means of enhancing attention, mental performance: children, adolescents and adults: 1 tablet 2-3 times a day for 3-10 days.If necessary, repeat 3-4 times or more per year.
Patients with chronic alcoholism and abuse alcohol appoint 1-3 tablets to receive 2-3 times a day for 4-5 days. If necessary, repeat 5-10 times a year.
In the treatment of alcohol withdrawal syndrome is prescribed in the first day 1-4 tablets 3-4 times a day (daily dose of 3-16 tablets), during the second day and then 1-2 tablets on reception 2-3 times a day (daily dose is 3-6 tablets) for 21-28 days.
The duration can be shortened to 10-14 days.
The greatest effect Biotredina ® achieved by its combination drug Glycine (100 mg tablet). Glycine taken under the tongue for 10-15 minutes before receiving Biotredina ® .
In remission for detecting latent craving for alcohol take 2-3 tablets Biotredina ® on an empty stomach. The appearance within 10-20 minutes of light dizziness, sedative effect, facial flushing, sweating indicates the presence of “hidden traction.” In these cases, it is recommended 5-10 days Biotredina Course ® 1-2 tablets 2-3 times a day with Glycine 100 mg under the tongue for 10-15 minutes before receiving Biotredina ® .
Dizziness, sweating, allergic reactions in case of intolerance of vitamin B 6 .
No cases of overdose have been identified.
Interaction with other drugs.
Incompatible with antipsychotic drugs, antidepressants, anxiolytics, barbiturates. Weaken the effect of antipsychotic drugs (neuroleptics), antidepressants, barbiturates and other drugs which depress the central nervous system.
Not recommended for use in the period of intoxication (as reduced therapeutic effect of the drug).